Poxel (SCY-770) Overview
- Status
-
Acquired/Merged
- Latest Deal Type
-
Asset Purch.
- Financing Rounds
-
1
Poxel (SCY-770) General Information
Description
An amp-activated protein kinase activator.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
- Tour Part Dieu, 129 rue Servient
- Lyon
- France
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Corporate Office
- Tour Part Dieu, 129 rue Servient
- Lyon
- France
Poxel (SCY-770) Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Poxel (SCY-770) Former Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Poxel (SCY-770) FAQs
-
Where is Poxel (SCY-770) headquartered?
Poxel (SCY-770) is headquartered in Lyon, France.
-
What industry is Poxel (SCY-770) in?
Poxel (SCY-770)’s primary industry is Buildings and Property.
-
Is Poxel (SCY-770) a private or public company?
Poxel (SCY-770) is a Private company.
-
What is the current valuation of Poxel (SCY-770)?
The current valuation of Poxel (SCY-770) is .
-
What is Poxel (SCY-770)’s current revenue?
The current revenue for Poxel (SCY-770) is .
-
Who are Poxel (SCY-770)’s investors?
Poxel has invested in Poxel (SCY-770).
-
When was Poxel (SCY-770) acquired?
Poxel (SCY-770) was acquired on 31-Mar-2026.
-
Who acquired Poxel (SCY-770)?
Poxel (SCY-770) was acquired by Scynexis.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process